NCT04135807
Implantable Microdevice In Primary Brain Tumors No drug interventions diagnostic 0 recruiting NCT04304300
Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes No drug interventions Not Available Not Available completed NCT05561374
Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma treatment 1 active_not_recruiting NCT02871843
RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas treatment 1 completed NCT01609790
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors treatment 2 completed NCT04047264
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies No drug interventions basic_science Not Available recruiting NCT05956821
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age treatment 1 / 2 recruiting NCT05331521
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). treatment 3 recruiting NCT05345002
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma treatment 2 recruiting NCT02903784
Neural Basis of Language Processing No drug interventions other Not Available completed NCT00575887
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma treatment 2 completed NCT02549833
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma treatment 1 active_not_recruiting NCT00080054
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas treatment 1 completed NCT02209428
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas treatment 2 unknown_status NCT02747407
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors Not Available Not Available completed NCT03353896
NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma No drug interventions treatment Not Available withdrawn NCT00591058
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma treatment 1 unknown_status NCT04105374
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma treatment 2 / 3 withdrawn NCT06161974
Study of Olutasidenib and Temozolomide in HGG treatment 2 not_yet_recruiting NCT06439420
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial No drug interventions treatment 2 recruiting NCT04623931
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas treatment 2 recruiting NCT03796273
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases treatment 0 terminated NCT00035373
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols No drug interventions Not Available Not Available terminated NCT00165360
Prolonged Daily Temozolomide for Low-Grade Glioma treatment 2 completed NCT06241391
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas No drug interventions diagnostic Not Available not_yet_recruiting NCT01089244
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma No drug interventions Not Available Not Available unknown_status NCT00717210
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide treatment 3 completed NCT00389090
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma treatment 2 terminated NCT03649464
Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants treatment 1 / 2 withdrawn NCT03180502
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma supportive_care 2 active_not_recruiting NCT02764151
First in Patient Study for PF-06840003 in Malignant Gliomas No drug interventions treatment 1 terminated NCT05512351
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma treatment 2 recruiting NCT00683761
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma No drug interventions treatment 1 / 2 unknown_status NCT00874861
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas treatment 0 completed NCT00360828
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas diagnostic 2 terminated NCT00392171
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) treatment 2 completed NCT02372409
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors treatment 2 terminated NCT04843085
Proteomic Characterization of Aggressive Oligodendrogliomas No drug interventions Not Available Not Available unknown_status NCT04970615
Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models No drug interventions Not Available Not Available unknown_status NCT01849952
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas No drug interventions Not Available Not Available recruiting NCT05513859
Investigational Imaging Technique During Brain Surgery No drug interventions diagnostic Not Available not_yet_recruiting NCT01836549
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors treatment 2 terminated NCT05624736
Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning No drug interventions Not Available Not Available recruiting NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 treatment 1 recruiting NCT02976441
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas treatment 0 withdrawn NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT00009035
Natural History of Patients With Brain and Spinal Cord Tumors No drug interventions Not Available Not Available completed NCT01649830
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma treatment 3 recruiting NCT02530320
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved treatment 2 completed NCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms No drug interventions treatment 1 recruiting NCT06038760
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) No drug interventions Not Available Not Available recruiting NCT04648462
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology No drug interventions Not Available Not Available recruiting NCT03900689
Social Determinants of Health in Glioblastoma Population No drug interventions Not Available Not Available completed NCT03014804
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma treatment 2 withdrawn NCT05190172
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas No drug interventions treatment Not Available recruiting NCT04702581
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery No drug interventions treatment 3 recruiting NCT02924038
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) treatment 1 terminated NCT00031538
Genetic Analysis of Brain Tumors No drug interventions Not Available Not Available terminated NCT02731521
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers No drug interventions Not Available Not Available completed NCT00897377
Treatment Strategy for Low-grade Gliomas treatment 3 terminated NCT02023905
Everolimus With and Without Temozolomide in Adult Low Grade Glioma treatment 2 terminated NCT02388659
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas No drug interventions Not Available Not Available completed NCT00213876
Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours No drug interventions Not Available Not Available completed NCT03027388
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma basic_science 2 completed